|
||||
|
PHYSICAL HEALTH
As well as the desired effects of psychostimulants, there are some negative health effects. These include:
The number of Australians using psychostimulants is increasing. Most people won't experience significant adverse effects from their drug use. However, the increase in availability and the use of more potent forms of methamphetamine such as crystal meth or ice means that regular heavy users are probably at risk of developing problems more quickly. Acute psychostimulant toxicity or poisoning
It is important to be aware that acute toxicity from using stimulants is not related to how you take it, or how much, how frequently, or how long you have used.
Sex There is evidence that the use of psychostimulants is associated with increased sexual risk-taking behaviour, including unsafe sex. Cocaine users especially, often feel invincible and that they don't need to worry about using condoms. Methamphetamine use has been associated with people who have increased number of sexual partners and more sexual activity, decreased condom use/higher rates of unprotected sex which may increase the chance of acquiring sexually transmitted infections, including HIV. Crystal meth and ice can make it difficult for some men to get or maintain an erection. To counter this, you may use Viagra or other impotence drugs. This presents a number of health risks including potential heart attacks. Teeth and gums Regular heavy use of crystal meth and ice, like other drugs, can cause a variety of mouth problems. Crystal meth use (especially smoking) can lead to bleeding gums, sores or loose teeth. This is because:
Pregnancy Current evidence suggests that the use of MDMA (ecstasy) in the first trimester of pregnancy can cause birth defects, but this is unlikely from amphetamine or cocaine use. The evidence is unclear as to other possible effects, especially from binge use. Babies born to women who have used amphetamines or cocaine in late third trimester are at risk of neonatal withdrawal symptoms. There is limited evidence that use of methamphetamine in pregnancy can result in damage to the placenta, higher rates of early delivery, small for gestational age babies, and heart and brain abnormalities in babies. Brain damage Methamphetamine affects a number of chemicals, known as neurotransmitters, responsible for inter-cellular communication within the brain. It remains unknown whether the use of stimulants causes permanent brain damage, and if it does, what effects this might have. Current evidence suggests that:
There is now emerging evidence for possible brain toxicity associated with continued use of methamphetamine, with certain regions of the brain more vulnerable than others. This toxicity is related to effects on dopamine, as well as damage to neurons and attached nerve fibres. Signs of toxicity include impairment in memory, concentration, motivation and planning ability.
Other effects Methamphetamine is able to raise the level of three important neurotransmitters - noradrenaline, dopamine and serotonin by several means, and it is this change which is responsible for the ‘high' you feel when you use methamphetamine. In addition, methamphetamine is felt to be more potent than other stimulants (such as ecstasy and cocaine), because of the longer time it remains in your blood stream (known as half life), and the ease with which the drug is able to interact with both brain cells (neurons) and attached nerve fibres within your brain. This potency factor may be a reason why people find it hard to stop using methamphetamine. Continued effects on neurotransmitters with use of methamphetamine, especially dopamine, is now known to be involved in development of dependence to the drug, withdrawal symptoms when you stop using, and psychiatric manifestations such as increased paranoia. Stimulant type drugs may also constrict the arteries supplying the bodies organs, including the heart, kidneys and brain, and this can lead to cell death as a result of loss of oxygen supply. Stimulant drug use may also:
Many of these effects contribute to the development of other effects, all of which contribute to the severity, morbidity and mortality associated with stimulant drug use.
|
||||
| Top of the page | ||||